F2 and hemorrhagic disease: Based on the current knowledge, there are several bleeding disorders that cannot be identified through routine clotting screens, which only assess prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen levels and platelet counts depending on the clinical information provided.